Spanish drugmaker Grifols SA paid a higher price to buy blood plasma from an entity linked to its controlling family than from third-party suppliers, according to a regulator’s findings submitted in a ... MSN: Grifols, S.A. (GRFS) to Double Plasma Production With New Spain Facility MarketWatch: Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance Grifols is a leading global healthcare company.

Understanding the Context

Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives. Grifols es una compañía global líder en el sector de la salud. Nuestros innovadores medicamentos derivados del plasma, otros productos biofarmacéuticos y soluciones en medicina transfusional permiten mejorar la calidad de vida de millones de pacientes en todo el mundo. Desde nuestra fundación en 1909, nuestro profundo y creciente conocimiento científico del plasma, diagnóstico y ...

Key Insights

Grifols is also a leader in transfusion medicine, helping ensure the safety of the world’s blood supply. In addition, we provide biological materials, including plasma, for life-science research and further manufacturing, and the company has a comprehensive portfolio of tools, information and services that enable hospitals to efficiently ... Discover Grifols Canada, a leader in biopharmaceutical solutions dedicated to high-quality plasma therapies that enhance patient care and outcomes. Join us in improving health in your community.